Abstract

Pancreatic β-cell loss induced by saturated free fatty acids (FFAs) is believed to contribute to type 2 diabetes. Previous studies have shown induction of endoplasmic reticulum (ER) stress, increased ubiquitinated proteins, and deregulation of the Bcl-2 family in the pancreas of type 2 diabetic patients. However, the precise mechanism of β-cell death remains unknown. In the present study we demonstrate that the FFA palmitate blocks the ubiquitin-proteasome system (UPS) and causes apoptosis through induction of ER stress and deregulation of Bcl-2 proteins. We found that palmitate and the proteasome inhibitor MG132 induced ER stress in β-cells, resulting in decreased expression of the prosurvival proteins Bcl-2, Mcl-1, and Bcl-XL, and upregulation of the prodeath BH3-only protein PUMA. On the other hand, pharmacological activation of the UPS by sulforaphane ameliorated ER stress, upregulated prosurvival Bcl-2 proteins, and protected β-cells from FFA-induced cell death. Furthermore, transgenic overexpression of Bcl-2 protected islets from FFA-induced cell death in vitro and improved glucose-induced insulin secretion in vivo. Together our results suggest that targeting the UPS and Bcl-2 protein expression may be a valuable strategy to prevent β-cell demise in type 2 diabetes.

Highlights

  • The prevalence of type 2 diabetes has doubled in the past 30 years and currently affects 360 million people worldwide [1]

  • In vitro studies have demonstrated that exposure to conditions observed in type 2 diabetes causes an imbalance between proapoptotic and prosurvival Bcl-2 proteins in β-cells leading to apoptosis [14,15,16]

  • We found that the saturated free fatty acids (FFAs) palmitate inhibits the ubiquitin-proteasome system (UPS) activity, generating an increase in ubiquitinated protein levels, a build-up of endoplasmic reticulum (ER) stress, and an imbalance in the expression of Bcl-2 protein family members, culminating in β-cell apoptosis

Read more

Summary

Introduction

The prevalence of type 2 diabetes has doubled in the past 30 years and currently affects 360 million people worldwide [1]. In vitro studies have demonstrated that exposure to conditions observed in type 2 diabetes (i.e., high concentrations of saturated FFAs or glucose) causes an imbalance between proapoptotic and prosurvival Bcl-2 proteins in β-cells leading to apoptosis [14,15,16]. Because of the correlation of increased protein ubiquitination and β-cell loss in type 2 diabetes, as well as the previous discovery that lipotoxicity induces apoptosis in βcells, we sought to determine whether UPS inactivation by FFAs constitutes the upstream signalling pathway of β-cell death. We found that the saturated FFA palmitate inhibits the UPS activity, generating an increase in ubiquitinated protein levels, a build-up of ER stress, and an imbalance in the expression of Bcl-2 protein family members, culminating in β-cell apoptosis

Materials and Methods
Results
Discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call